PMC:7445716 / 11109-11428 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T20","span":{"begin":235,"end":248},"obj":"Body_part"}],"attributes":[{"id":"A20","pred":"fma_id","subj":"T20","obj":"http://purl.org/sig/ont/fma/fma5865"}],"text":"Even if ascending weakness evolving into flaccid tetraparesis (76.4%, 55/72) and spreading/persistence of sensory symptoms (84.7%, 61/72) represented the most common clinical evolutions, 50.0% (36/72) and 23.6% (17/72) patients showed cranial nerve deficits and dysphagia, respectively, during disease course (Table 1)."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T12","span":{"begin":235,"end":248},"obj":"Body_part"},{"id":"T13","span":{"begin":243,"end":248},"obj":"Body_part"}],"attributes":[{"id":"A12","pred":"uberon_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/UBERON_0001785"},{"id":"A13","pred":"uberon_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/UBERON_0001021"}],"text":"Even if ascending weakness evolving into flaccid tetraparesis (76.4%, 55/72) and spreading/persistence of sensory symptoms (84.7%, 61/72) represented the most common clinical evolutions, 50.0% (36/72) and 23.6% (17/72) patients showed cranial nerve deficits and dysphagia, respectively, during disease course (Table 1)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T71","span":{"begin":194,"end":196},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"},{"id":"T72","span":{"begin":243,"end":248},"obj":"http://purl.obolibrary.org/obo/UBERON_0001021"}],"text":"Even if ascending weakness evolving into flaccid tetraparesis (76.4%, 55/72) and spreading/persistence of sensory symptoms (84.7%, 61/72) represented the most common clinical evolutions, 50.0% (36/72) and 23.6% (17/72) patients showed cranial nerve deficits and dysphagia, respectively, during disease course (Table 1)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"227","span":{"begin":218,"end":226},"obj":"Species"},{"id":"235","span":{"begin":17,"end":25},"obj":"Disease"},{"id":"236","span":{"begin":40,"end":60},"obj":"Disease"},{"id":"237","span":{"begin":234,"end":270},"obj":"Disease"}],"attributes":[{"id":"A227","pred":"tao:has_database_id","subj":"227","obj":"Tax:9606"},{"id":"A235","pred":"tao:has_database_id","subj":"235","obj":"MESH:D018908"},{"id":"A236","pred":"tao:has_database_id","subj":"236","obj":"MESH:C565722"},{"id":"A237","pred":"tao:has_database_id","subj":"237","obj":"MESH:D003680"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Even if ascending weakness evolving into flaccid tetraparesis (76.4%, 55/72) and spreading/persistence of sensory symptoms (84.7%, 61/72) represented the most common clinical evolutions, 50.0% (36/72) and 23.6% (17/72) patients showed cranial nerve deficits and dysphagia, respectively, during disease course (Table 1)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T84","span":{"begin":0,"end":319},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Even if ascending weakness evolving into flaccid tetraparesis (76.4%, 55/72) and spreading/persistence of sensory symptoms (84.7%, 61/72) represented the most common clinical evolutions, 50.0% (36/72) and 23.6% (17/72) patients showed cranial nerve deficits and dysphagia, respectively, during disease course (Table 1)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T42","span":{"begin":49,"end":61},"obj":"Phenotype"},{"id":"T43","span":{"begin":262,"end":271},"obj":"Phenotype"}],"attributes":[{"id":"A42","pred":"hp_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/HP_0002273"},{"id":"A43","pred":"hp_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/HP_0002015"}],"text":"Even if ascending weakness evolving into flaccid tetraparesis (76.4%, 55/72) and spreading/persistence of sensory symptoms (84.7%, 61/72) represented the most common clinical evolutions, 50.0% (36/72) and 23.6% (17/72) patients showed cranial nerve deficits and dysphagia, respectively, during disease course (Table 1)."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T97","span":{"begin":235,"end":248},"obj":"UBERON:0001785"}],"text":"Even if ascending weakness evolving into flaccid tetraparesis (76.4%, 55/72) and spreading/persistence of sensory symptoms (84.7%, 61/72) represented the most common clinical evolutions, 50.0% (36/72) and 23.6% (17/72) patients showed cranial nerve deficits and dysphagia, respectively, during disease course (Table 1)."}